已收盤 12-24 16:00:00 美东时间
-0.130
-0.44%
William Blair analyst Jared Haase initiates coverage on Pennant Gr (NASDAQ:PNTG) with a Outperform rating.
12-08 22:31
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
12-03 09:58
Truist Securities analyst David Macdonald upgrades Pennant Gr (NASDAQ:PNTG) from Hold to Buy and raises the price target from $28 to $34.
12-03 00:08
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
11-19 11:01
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
11-18 15:28
RBC Capital analyst Ben Hendrix maintains Pennant Gr (NASDAQ:PNTG) with a Outperform and raises the price target from $34 to $39.
11-17 21:10
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
今日重点评级关注:HC Wainwright & Co.:维持Alto Neuroscience"买入"评级,目标价从10美元升至50美元;RBC Capital:维持Precision Drilling"跑赢大市"评级,目标价从110美元升至117美元
10-27 09:45
Jefferies analyst Brian Tanquilut initiates coverage on Pennant Gr (NASDAQ:PNTG) with a Buy rating and announces Price Target of $30.
10-24 18:25
今日重点评级关注:HC Wainwright & Co.:维持Inventiva"买入"评级,目标价从20美元升至24美元;摩根大通:维持BioMarin Pharmaceutical"超配"评级,目标价从116美元升至119美元
10-10 11:36